New Zealand · Delayed Price · Currency is NZD Oceania Healthcare Earnings Call Transcripts
Fiscal Year 2026
-
Record EBITDA and sales volumes achieved, with net debt and gearing significantly reduced. Operational improvements and targeted divestments strengthened cash flow and balance sheet, positioning for resumed dividends and growth in FY 2027.
-
Stabilization initiatives drove a 23% increase in underlying EBITDA and improved sales and occupancy, with gearing reduced to 34.8% and strong momentum in applications. Debt repayment is set to accelerate in the second half, supported by divestments and higher-value sales.
Fiscal Year 2025
-
The meeting reviewed strong asset growth, a modernized portfolio, and improved financial leverage, but no dividend was declared for FY 2025. Strategic plans focus on care quality, sustainability, and operational efficiency, with robust risk management and board oversight.
-
Positive momentum in FY 2025 with improved sales, cost control, and asset growth. Underlying EBITDA rose 4.1% year-over-year, gearing decreased, and a major cost-out program is underway. Focus remains on sales, debt reduction, and portfolio modernization.
-
Underlying EBITDA rose 2.6% year-over-year, with strong cash inflow and improved gearing, but high unsold stock and rising interest costs remain key risks. Sales acceleration, cost reduction, and portfolio rebalancing are top priorities, with dividend resumption dependent on sales and gearing.
Fiscal Year 2024
-
The meeting highlighted strong financial growth, ongoing portfolio transformation, and a focus on sustainability and risk management. Shareholders discussed share price, dividends, and resident amenities, with the board reaffirming its commitment to strategic investment and operational improvements.